Table 1

Distribution of disease categories
Groups Findings and number of dogs
SRMA untreated (SRMA) Dogs with fever, cervical pain, neutrophilic leukocytosis and pleocytosis. These dogs were not pre-treated with glucocorticosteroid (n = 36)
SRMA relapse (SRMA R) Dogs with a previous diagnosis of SRMA in which clinical signs recurred despite glucocorticosteroid treatment (n = 9)
SRMA therapy (SRMA Th) Dogs with previous diagnosis of SRMA under long-term glucocorticosteroid treatment. These dogs did not show any clinical signs at the time of sampling (n = 20)
Idiopathic epilepsy (IE) Dogs with clinical, CSF, MRI findings consistent with idiopathic epilepsy (n = 22)
Meningoencephalomyelitides (ME) Dogs with clinical, CSF, MRI and/or pathological findings consistent with meningoencephalomyelitides: granulomatous meningoencephalomyelitis (n = 14), necrotising encephalitides (n = 1), meningoencephalomyelitis of unknown origin (n = 8), infectious encephalitides (n = 24)
Miscellaneous non-inflammatory CNS diseases (CNS-Mix). Dogs with miscellaneous not primarily inflammatory neurological diseases: intervertebral disc disease (n = 9), neoplasia of the CNS (n = 24), cerebrovascular disease (n = 4), degenerative myelopathy (n = 1)
Systemic inflammatory diseases (Syst. Inflam.) Dogs affected with systemic inflammatory diseases, but not suffering from neurological conditions (n = 16)
Healthy Healthy dogs (n = 20)

CSF: cerebrospinal fluid; CNS: central nervous system; MRI: magnetic resonance imaging; SRMA: steroid-responsive meningitis-arteritis.

Maiolini et al.

Maiolini et al. BMC Veterinary Research 2013 9:23   doi:10.1186/1746-6148-9-23

Open Data